Related Experiment Videos
Fatty liver in the intensive care unit
Nicolas Paquot1, Jean Delwaide
1Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart-Tilman, University of Liège, Belgium. nicolas.paquot@chu.ulg.ac.be
Current Opinion in Clinical Nutrition and Metabolic Care
|February 18, 2005
Summary
Non-alcoholic steatohepatitis involves multiple factors, with mitochondrial dysfunction playing a key role in liver injury and progression to fibrosis. Adapted nutrition can help prevent fatty liver in intensive care unit patients.
Area of Science:
- Hepatology
- Gastroenterology
- Metabolic Diseases
Background:
- Non-alcoholic steatohepatitis (NASH) is a liver disease characterized by fat accumulation and inflammation, often linked to insulin resistance.
- Secondary NASH can occur in intensive care unit (ICU) patients receiving total parenteral nutrition (TPN).
- Understanding NASH pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To review recent advancements in understanding the pathogenesis of non-alcoholic steatohepatitis.
- To explore the multifactorial mechanisms contributing to NASH development and progression.
- To discuss the role of nutrition in preventing fatty liver disease in specific patient populations.
Main Methods:
- Literature review of recent studies on NASH pathogenesis.
- Analysis of factors contributing to liver steatosis and steatohepatitis.
- Evaluation of nutritional interventions in preventing fatty liver disease.
Main Results:
- NASH pathogenesis involves fatty acids, oxidative stress, cytokines, genetic factors, and mitochondrial dysfunction.
- Mitochondrial dysfunction is critical, leading to reactive oxygen species generation and lipid peroxidation, promoting fibrosis.
- In ICU patients, adapted glucose-lipid ratios and specific lipid emulsions (fish oils) can prevent fatty liver; however, acute phase responses can still induce it.
Conclusions:
- NASH pathogenesis is complex and multifactorial, with mitochondrial dysfunction consistently playing a central role.
- Nutritional strategies, particularly adapted glucose-lipid ratios, can partially prevent fatty liver in ICU settings.
- Further research into the intricate mechanisms of NASH is warranted to improve patient outcomes.